These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15752147)

  • 1. Minimum conditions of major histocompatibility complex compatibility and recipient immune compromise required to establish donor white blood cell persistence in a murine transfusion model.
    Lee TH; Wen L; Montalvo L; Esho O; Lowell C; Reed W; Busch M
    Transfusion; 2005 Mar; 45(3):301-14. PubMed ID: 15752147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient CD8+ cells are responsible for the rapid elimination of allogeneic donor lymphoid cells.
    Fast LD
    J Immunol; 1996 Dec; 157(11):4805-10. PubMed ID: 8943382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility.
    Lee TH; Reed W; Mangawang-Montalvo L; Watson J; Busch MP
    Transfusion; 2001 May; 41(5):637-42. PubMed ID: 11346700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
    Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
    Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury.
    Lee TH; Paglieroni T; Utter GH; Chafets D; Gosselin RC; Reed W; Owings JT; Holland PV; Busch MP
    Transfusion; 2005 Aug; 45(8):1280-90. PubMed ID: 16078913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells.
    Oikawa A; Ito K; Seguchi H; Okabe M; Migishima F; Eshima K; Azuma S; Song SY; Kaneko T; Shinohara N
    Transplantation; 2007 Jul; 84(1):23-30. PubMed ID: 17627233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients.
    Lee TH; Paglieroni T; Ohto H; Holland PV; Busch MP
    Blood; 1999 May; 93(9):3127-39. PubMed ID: 10216112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
    Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
    Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.
    Aslam R; Speck ER; Kim M; Freedman J; Semple JW
    Transfusion; 2008 Sep; 48(9):1778-86. PubMed ID: 18522705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immune tolerance across major histocompatibility complex barrier by transfusion of ultraviolet B-irradiated immature dendritic cells.
    Xia CQ; Kao KJ
    Transfusion; 2005 Feb; 45(2):181-8. PubMed ID: 15660825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
    Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
    Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts.
    Kobayashi T; Harb G; Rajotte RV; Korbutt GS; Mallett AG; Arefanian H; Mok D; Rayat GR
    Xenotransplantation; 2006 Nov; 13(6):547-59. PubMed ID: 17059582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning.
    Rubio MT; Zhao G; Buchli J; Chittenden M; Sykes M
    Clin Immunol; 2006 Jul; 120(1):33-44. PubMed ID: 16675304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual kinetics of white cell clearance in transfused mice.
    Goodarzi MO; Lee TH; Pallavicini MG; Donegan EA; Busch MP
    Transfusion; 1995 Feb; 35(2):145-9. PubMed ID: 7825210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.